Moreover, univariate analysis showed that gender, TNM stage, smoking index, treatment regimens, pathological type, EGFR mutation, Kristen rat sarcoma viral oncogene homolog (KRAS) mutation, PLR ratio, neutrophil-to-lymphocyte ratio (NLR) ratio, serum LDH, serum Cyfra211, and Ki-67 were correlated with OS and first-line therapeutic outcomes in NSCLC patients (Table 2). This evidence concerns the gene EGFR and non-small cell lung carcinoma.